Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  DLK1/ EPHA2/HBB/NRP1/RGS5/TEM1 peptide-pulsed alpha-type-1 polarized dendritic cell vaccine
Find trials that include:  Any drugs shown
Results 1-2 of 2 for your search:
Start Over
Type-1-polarized Dendritic Cell Vaccine, Interferon Alpha-2b, Rintatolimod, and Celecoxib in Treating Patients with Chemo-refractory Metastatic Colorectal Cancer
Status: Not yet active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: UPCI 15-023, NCI-2016-00923, NCT02615574
Dendritic Cell Vaccine and Gemcitabine Hydrochloride in Treating Patients with Metastatic Breast Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CASE 3113, NCI-2014-00265, 046203, 3113, NCT02479230
Start Over